Diffuse Large B-Cell Lymphoma Market Business Overview, Product Type, Regional Outlook and Forecast Period 2017-2025
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non hodgkin lymphoma (NHL) and is the main reason behind more than 30% of the newly diagnosed cancer cases in the U.S. alone.
View full press release